Breaking News: First-in-Class Radioligand Therapy Approved for Advanced Prostate Cancer
What this means for patients: Today, a new treatment known as 177lutetium-PSMA-617 (Lu-PSMA; trade name Pluvicto®) was approved by the FDA for certain patients with advanced prostate cancer. This medicine delivers a...Read More
How PCF is Furthering Health Equity and Combating Prostate Cancer Disparities
In the U.S., 1 in 8 men in their lifetime will be diagnosed with prostate cancer. But the disease does not affect all men equally. 1 in 6 Black men...Read More
Roasted Spring Brussels Sprouts
It’s spring. That means the grocery stores will begin to fill with a glorious abundance of seasonal fruits and vegetables. For some, April also means a family gathering filled with...Read More
Highlights of ASCO GU 2022, Part 1
Combination treatments for metastatic disease Clinicians and researchers gathered last month at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) — some in-person in San Francisco, some...Read More
Less Meat, Less Prostate Cancer?
People often have questions about whether specific foods—such as meat—might increase their risk of prostate cancer or other diseases. A new study of more than 200,000 men in the U.K....Read More
Charles L.
My wife buried my dog. I was diagnosed in 2019 and given a grim prognosis of maybe 2 years. My wife has been a rock and is very active in...Read More
Kimberly N.
On December 25, 2019 I was thrust into a role I never thought I would have to be, cancer caregiver to my 10 year-old son. Only one year earlier I...Read More
